Kelly DL - Search Results

1

Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.

Ball MP, Warren KR, Feldman S, McMahon RP, Kelly DL, Buchanan RW. Ball MP, et al. Among authors: kelly dl. Clin Schizophr Relat Psychoses. 2011 Apr;5(1):17-25. doi: 10.3371/CSRP.5.1.3. Clin Schizophr Relat Psychoses. 2011. PMID: 21459735 Clinical Trial.

2

Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse.

Conley RR, Kelly DL, Gale EA. Conley RR, et al. Among authors: kelly dl. Schizophr Res. 1998 Sep 7;33(1-2):95-101. doi: 10.1016/s0920-9964(98)00062-0. Schizophr Res. 1998. PMID: 9783349

3

Rehospitalization rates of patients recently discharged on a regimen of risperidone or clozapine.

Conley RR, Love RC, Kelly DL, Bartko JJ. Conley RR, et al. Among authors: kelly dl. Am J Psychiatry. 1999 Jun;156(6):863-8. doi: 10.1176/ajp.156.6.863. Am J Psychiatry. 1999. PMID: 10360124

4

Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-response.

Conley RR, Tamminga CA, Kelly DL, Richardson CM. Conley RR, et al. Among authors: kelly dl. Biol Psychiatry. 1999 Jul 1;46(1):73-7. doi: 10.1016/s0006-3223(99)00029-3. Biol Psychiatry. 1999. PMID: 10394475 Clinical Trial.

5

Differential olanzapine plasma concentrations by sex in a fixed-dose study.

Kelly DL, Conley RR, Tamminga CA. Kelly DL, et al. Schizophr Res. 1999 Nov 30;40(2):101-4. doi: 10.1016/s0920-9964(99)00053-5. Schizophr Res. 1999. PMID: 10593449

6

Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.

Kelly DL, Nelson MW, Love RC, Yu Y, Conley RR. Kelly DL, et al. Psychiatr Serv. 2001 May;52(5):676-8. doi: 10.1176/appi.ps.52.5.676. Psychiatr Serv. 2001. PMID: 11331805

7

Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials.

McMahon RP, Kelly DL, Kreyenbuhl J, Kirkpatrick B, Love RC, Conley RR. McMahon RP, et al. Among authors: kelly dl. Neuropsychopharmacology. 2002 Apr;26(4):537-45. doi: 10.1016/S0893-133X(01)00387-6. Neuropsychopharmacology. 2002. PMID: 11927178

8

Clozapine treatment in patients with prior substance abuse.

Kelly DL, Gale EA, Conley RR. Kelly DL, et al. Can J Psychiatry. 2003 Mar;48(2):111-4. doi: 10.1177/070674370304800208. Can J Psychiatry. 2003. PMID: 12655909

9

Current status of antipsychotic treatment.

Conley RR, Kelly DL. Conley RR, et al. Among authors: kelly dl. Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):123-8. doi: 10.2174/1568007024606221. Curr Drug Targets CNS Neurol Disord. 2002. PMID: 12769630 Review.

10

Rehospitalization risk with second-generation and depot antipsychotics.

Conley RR, Kelly DL, Love RC, McMahon RP. Conley RR, et al. Among authors: kelly dl. Ann Clin Psychiatry. 2003 Mar;15(1):23-31. doi: 10.1023/a:1023276509470. Ann Clin Psychiatry. 2003. PMID: 12839430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

426 results

Search Page

Filters